LOVFF (Cannara Biotech) EBIT per Share : $0.07 (TTM As of Nov. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech EBIT per Share?

Cannara Biotech's EBIT per Share for the three months ended in Nov. 2024 was $0.03. Its EBIT per Share for the trailing twelve months (TTM) ended in Nov. 2024 was $0.07.

During the past 12 months, the average EBIT per Share Growth Rate of Cannara Biotech was -39.20% per year. During the past 3 years, the average EBIT per Share Growth Rate was 180.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Cannara Biotech's EBIT per Share or its related term are showing as below:

LOVFF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 180.2 Med: 180.2 Max: 180.2
Current: 180.2

During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Cannara Biotech was 180.20% per year. The lowest was 180.20% per year. And the median was 180.20% per year.

LOVFF's 3-Year EBIT Growth Rate is ranked better than
99.4% of 831 companies
in the Drug Manufacturers industry
Industry Median: 7 vs LOVFF: 180.20

Cannara Biotech's EBIT for the three months ended in Nov. 2024 was $2.92 Mil.

Cannara Biotech EBIT per Share Historical Data

The historical data trend for Cannara Biotech's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech EBIT per Share Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

EBIT per Share

Get a 7-Day Free Trial

-0.13

0.04

0.09

0.07

Cannara Biotech Quarterly Data
	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24
EBIT per Share	Get a 7-Day Free Trial															0.03	-0.02	0.03	0.03	0.03

Cannara Biotech EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Cannara Biotech's EBIT per Share for the fiscal year that ended in Aug. 2024 is calculated as

	EBIT per Share		(A: Aug. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	6.453	/	91.385
=	0.07

Cannara Biotech's EBIT per Share for the quarter that ended in Nov. 2024 is calculated as

	EBIT per Share		(Q: Nov. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	2.923	/	91.578
=	0.03

EBIT per Share for the trailing twelve months (TTM) ended in Nov. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.07

Cannara Biotech (OTCPK:LOVFF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Cannara Biotech EBIT per Share Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (OTCPK:LOVFF) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

8CB0:Germany LOVE:Canada

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .